Showing 1 - 10 of 22,665
-competitive patent settlements and hold-ups in relation to standard setting processes, in addition to the modern focus on mergers that … potentially lessen incentives for innovation and on abuse of dominance/single firm exclusionary practices in IP-intensive network … importance for economic advancement and prosperity, having a direct bearing on innovation, growth and the diffusion of new …
Persistent link: https://www.econbiz.de/10011723874
Persistent link: https://www.econbiz.de/10000331005
,the US provides robust patent protection across the whole range of information patents, while Europe has expressly declined … to embrace business method patents and patenting of software inventions remains uncertain. For each of these two areas …
Persistent link: https://www.econbiz.de/10014113743
Persistent link: https://www.econbiz.de/10013040928
Persistent link: https://www.econbiz.de/10014233358
Persistent link: https://www.econbiz.de/10012800211
This essay raises questions about the Patent Harmonization Treaty. addressing the overall direction of harmonization in … underlying goals of patent harmonization with those of the current United States patent system. The article contends that the … harmonization, in contrast, are fundamentally different. To be valid, then, patent harmonization may require a basic shift in the …
Persistent link: https://www.econbiz.de/10014186637
The COVID-19 crisis intensified decade-long debates on the interaction between intellectual property rights (IPRs), competition law and access to affordable life-saving treatments and vaccines. Compulsory licensing of patented medicines is a tried-and-tested method to expand access, particularly...
Persistent link: https://www.econbiz.de/10014541546
specific therapy. This particular field brings along the gene related patent applications. In recent years, ethical sides …, policy considerations on patent applications in gene sequences, and gene related diagnostic and treatment methods led to many … debates among biotech/pharma companies, patent stakeholders, researchers, clinicians, and patients. Although the patent system …
Persistent link: https://www.econbiz.de/10014094257